A Thoughtful Review When Adding New Prescriptions

A new prescription is more than a new bottle — it is a change that warrants taking time to review and understand how it will affect you. Four questions can surface the answers needed to understand what to expect from a new prescription. These questions open up a conversation to ensure this is the most appropriate choice in your situation.

This guide walks through how age influences prescription choices, how to collaborate with the clinician on prescription options, the four questions that surface the answers families need, and the situations where a second opinion (from a pharmacist or a geriatrician) is worth seeking out. The goal is to have an informed conversation around treatment options, to identify the option that is best aligned with your needs and your situation.

Why thoughtful review matters more after seventy-five

The biology behind polypharmacy — slower kidneys, slower liver, more drug interactions on an already-long list — means a new prescription at eighty-three is not the same impact as a new prescription at fifty-three. The benefit may be smaller; the side-effect profile is often larger; the risk of an interaction climbs. None of that means the prescription is the wrong choice. It does mean the decision deserves five minutes of conversation.

Most prescribers know this. The reality of a fifteen-minute primary-care visit is that the prescription often gets written without the full conversation outlining the purpose of the medication, possible side effects, or answering questions. The family's job is not to refuse the medication — refusing without information is rarely the right move — but to slow the conversation down enough that the reasoning becomes visible.

When further review is most useful

A few patterns surface again and again in family-support communities and in the geriatrics literature. Each one is a moment when the family should consider asking the four questions below before the bottle gets filled.

• A new prescription written quickly, without explanationVisits where the prescription is given, often as the appointment is wrapping up, without a clear stated reason on the purpose of the medication or what to expect. Not necessarily wrong, but worth a slower conversation before filling.
• A new medication added on top of five or morePolypharmacy is the field's flag for "stop and think." Every new medication after the fifth carries a higher interaction risk. The question "could anything come off?" matters most here.
• A medication for a side effect of another medicationThe classic prescribing cascade. New constipation treated with a new bottle; new dizziness treated with a new bottle; the underlying medication never reconsidered. Worth asking whether the original prescription could be adjusted instead.
• A medication whose stated purpose overlaps with one already on the listTwo blood-pressure medications in the same class; two pain medications; two sleep medications. Sometimes intentional, almost always worth asking about.
• A medication on the Beers List for this age groupSee the related piece on the Beers Criteria. Some medications carry elevated risk in older adults specifically. Not banned, but worth a conversation about whether the benefit justifies the risk.
• A new prescription right after a hospital dischargeDischarge medication lists are notorious for accumulating hospital-only medications that did not need to come home. A pharmacist review in the first week after discharge can ensure the medication changes are clear.

The four questions

These four questions are short, they are easy to remember, and they reliably produce useful information.

• "What is this for?"Sounds obvious, but it is the question families forget to ask most often. The answer becomes the "reason" column in the master medication list.
• "What does success look like in eight weeks?"How will we know it is working? What are we tracking — symptoms, lab values, blood pressure, sleep? Without an answer, the medication has no exit ramp. The exit-ramp question is the deprescribing conversation in disguise.
• "What should I watch for in the first two weeks?"New side effects, new dizziness, new confusion, new fatigue. The first two weeks are when most adverse reactions surface. Knowing in advance what counts as "report this" lowers the threshold for the family to call.
• "Could anything come off the list at the same time?"The deprescribing question, asked plainly. Sometimes the answer is no. Sometimes the answer is yes and no one has had time to bring it up. Either answer is worth knowing.

How to talk with the prescriber about medication choices

Approaching a conversation around medication choices by saying 'help me understand' almost always opens a conversation. Pushing back against clinical advice by saying 'I read on the internet that this medication is dangerous' changes the tone from collaborative to challenging. The phrasing that is often helpful is: 'I want to make sure I understand what we are starting and why — can we walk through it together?'

Bringing the printed master medication list to the visit makes the conversation easier. The master medication list shows the prescriber what is already in the picture. It shifts the conversation from 'should we add this?' to 'does this fit with everything else?' This gives the provider the opportunity to spend a little more time with you on this question.

When a second opinion is helpful

Two kinds of second opinions are widely available and often free or low-cost. The first is a pharmacist consultation — both the retail pharmacist who fills the prescription (a five-minute conversation at the counter is almost always free) and a structured medication therapy management (MTM) review through Medicare Part D, which most beneficiaries on multiple medications are eligible for annually at no cost. The second is a geriatrician's review, which is most useful for adults over seventy-five on five or more medications.

The second-opinion conversation is not a referendum on the original prescriber. It is a structured review by a clinician whose specific job is to look at the whole list at once. Most primary-care doctors welcome the second opinion, particularly when the family brings the report back and asks the primary doctor to weigh in on the recommendations.

For the deeper piece on what a structured annual medication review looks like and how to get one, see The medication review every senior should get every year. For the related context on why polypharmacy makes the pushback conversation more important after seventy-five, see What is polypharmacy — and why it's dangerous after 75. For the related conversation about medications that look helpful at first but carry hidden risk for older adults, see The Beers List: medications older adults shouldn't take. For the broader playbook this conversation feeds into, see The Caregiver's Guide to Managing Your Parent's Medications. For the longer pillar, the Medications hub has the full set.